865758-96-9,
2-((6-Chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile,
2-[(6-CHLORO-3,4-DIHYDRO-3-METHYL-2,4-DIOXO-1(2H)-PYRIMIDINYL)METHYL]BENZONITRILE,
Alogliptin Impurity 09,
C13H10ClN3O2,
2-[(6-chloro-3-methyl-2,4-dioxopyrimidin-1-yl)methyl]benzonitrile,
2-((6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H) -yl)methyl)benzonitrile,
Benzonitrile,2-[(6-chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2H)-pyriMidinyl)Methyl]-,
BVUJISIVAHYNLI-UHFFFAOYSA-N,
SCHEMBL389683,
Alogliptin Related Compound 28,
CTK8B6401,
DTXSID10463107,
BCP08889,
CS-M2296,
KS-00000Q0P,
ANW-53401,
MFCD11558902,
ZINC40433892,
AKOS015999478,
AB64299,
AC-25788,
AK-93373,
AS-19917,
AJ-101739,
DB-076686,
4CH-018368,
AM20090701,
FT-0664651,
Z1750,
2-(6-CHLORO-3-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-YLMETHYL)-BENZONITRILE,
2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-benzonitrile,
2-[6-Chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidine-1(2H)-ylmethyl]benzonitrile,
Benzonitrile, 2-[(6-chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-,
CID11346416,
2-[(6-chloro-3-methyl-2,4-dioxo-pyrimidin-1-yl)methyl]benzonitrile,